Search Results 621-630 of 17981 for Hepatitis b
s, Liver problems, Primary sclerosing cholangitis, Hepatitis B, Cholangiocarcinoma, Portal hypertension, Liver cancer, Alcoholic hepatitis, Hepatocellular ...
... B-Cell Non-Hodgkin Lymphoma ... History of liver disease such as cirrhosis, chronic active hepatitis, chronic persistent hepatitis or hepatitis B or C.
Hepatitis B infection, history of or; Heart rhythm problem (eg, QT prolongation) or; Kidney failure, acute or; Liver disease, mild or; Seizures, history of—Use ...
Hepatitis B, history of or; Immune system problem or; Primary sclerosing cholangitis (bile duct disease) or; Tuberculosis, history of or; Granulomatosis ...
Patients who are immune to hepatitis B (anti-Hepatitis B surface antibody positive) are eligible (i.e., patients immunized against hepatitis B). In some ...
Patient must be tested for hepatitis B within 28 days prior to randomization. Patient must not have active (chronic or acute) hepatitis B virus (HBV) infection.
Positive Hepatitis B Surface Antigen (HepBsAg) (indicative of chronic Hepatitis B or recent acute hepatitis B);; Negative HepBsAg and positive for hepatitis B ...
Active viral hepatitis. Subjects positive for hepatitis B surface antigen not on antiviral treatment/prophylaxis or subjects with detectable hepatitis B DNA:.
These cells are called B cells, also known as B lymphocytes. In MZL, changes ... pylori, hepatitis C, Chlamydophila psittaci, Campylobacter jejuni and Borrelia ...
Horsley, M.D.. Internist. Phoenix, AZ. Areas of focus: LGBT health care, Erectile dysfunction, Sexual dysfunction, Hepatitis C, Hepatitis B, Sexually ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.